Binding sites for ouabain in human and rat erythrocytes and in rat heart cells

  • Michael Heller
Conference paper

Summary

The presence and properties of two classes of binding sites for digitalis in erythrocytes and in heart cells are reviewed. Methods to distinguish between these two binding sites are summarized for intact cells and for their membranes. Our biochemical data do not suggest a physiological role for each class of sites.

The membrane sites were modified by varying (a) the content of cholesterol or (b) the distribution of fatty acids leading to changes in the microviscosity thus affecting the degree of binding of ouabain to the two classes of sites. Oxidation of ouabain with periodate forms a di-aldehyde which could bind via Schiff base to the digitalis sites but could also attach covalently to these sites. The role of the sugar moiety in the process of ouabain binding becomes of increasing importance.

A mild, controlled periodate oxidation of ouabain, especially in presence of phosphate cleaves only the bond between C-2 and C-3 of the rhamnose without affecting the steroid moiety. The periodate oxidation provided additional information for assigning a distorted chair conformation or a transient boat conformation for rhamnose in ouabain. It was also established by 1H NMR spectroscopy that this chair conformation is a 1C4 pyranose ring.

Key words

Cardiomyocytes erythrocytes membrane lipids receptors ouabain 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adams RJ, Schwartz A, Grupp G, Grupp I, Lee SW, Wallick ET, Powell T, Twist VW, Gathiram P (1982) High-affinity ouabain binding site and low-dose positive inotropic effect in rat myocardium. Nature 296: 167–168PubMedCrossRefGoogle Scholar
  2. 2.
    Barry WH, Biedert S, Miura DS, Smith TW (1981) Changes in cellular Na+, K+, and Ca++ contents, monovalent cation transport rate, and contractile state during washout of cardiac glycosides from cultured chick heart cells. Circ Res 49: 141–149PubMedCrossRefGoogle Scholar
  3. 3.
    Benenson A, Heller M, Pinson A, Mersel M (1982) Advances in studies on heart metabolism, ed Caldarera CM and Harris P, pp 49–56, Proteolipid and lipid moieties in SarcolemmaGoogle Scholar
  4. 4.
    Brown L, Thomas R (1983) Comparison of the inotropic potencies of some synthetic and naturally occurring cardiac glycosides using isolated left atrium of guinea pig. Arzneim Forsch 33: 814–817Google Scholar
  5. 5.
    Erdmann E, Philipp G, Scholz H (1980) Cardiac glycoside receptor, (Na+ + K+)-ATPase activity and force of contraction in rat heart. Biochem Pharmacol 29: 3219–3229PubMedCrossRefGoogle Scholar
  6. 6.
    Erdmann E, Brown L, Krawietz W, Werdan K (1983) Quantitative evaluation of 3H-ouabain binding to contracting heart muscle, positive inotropy, Na,K-ATPase inhibition, and 86Rb+ uptake in several species. In: Hoffmann JF, Forbush B (eds) Current Topics in Membranes and Transport, Vol 19, Structure, mechanism and function of Na/K pump. Academic Press, New York, p 891–895Google Scholar
  7. 7.
    Friedman I, Schwalb H, Hallaq H, Pinson A, Heller M (1980) Interactions of cardiac glycosides with cultured cardiac cells. Biochim Biophys Acta 598: 272–284PubMedCrossRefGoogle Scholar
  8. 8.
    Godfraind T (1981) In: Greeff K (ed) Handbook of Experimental Pharmacology, Vol 56/1 p 381Google Scholar
  9. 9.
    Grupp IL, Grupp G, Schwartz A (1981) Digitalis receptor desensitization in rat ventricle: Ouabain produces two inotropic effects. Life Sci 29: 2789–2794PubMedCrossRefGoogle Scholar
  10. 10.
    Hegyvary C (1975) Covalent labeling of the digitalis-binding component of plasma membranes. Mol Pharmacol 11: 588–594PubMedGoogle Scholar
  11. 11.
    Heller M, Beck S (1978) Interactions of cardiac glycosides with cells and membranes. Biochim Biophys Acta 514: 332–347PubMedCrossRefGoogle Scholar
  12. 12.
    Heller M, Beck S, Friedman I, Hallaq H, Mersel M, Pinson A, Schwalb H, Smith E, Yehiel E (1979) Intl Symp of Intl Soc Heart Research, pp 97–110, Digitalis and the plasma membraneGoogle Scholar
  13. 13.
    Mersel M, Amar A, Benenson A, Heller M, Hallaq H, Padieu P, Pinson A (1982) Advances in studies on heart metabolism, ed Caldarera CM and Harris P, pp 89–93, Sarcolemma fluidityGoogle Scholar
  14. 14.
    Noble D (1980) Mechanism of action of therapeutic levels of cardiac glycosides. Cardiovasc Res 14: 495–514PubMedCrossRefGoogle Scholar
  15. 15.
    Peterson GL, Churchill L, Fisher JA, Hokin LE (1982) Structure and biosynthesis of (Na,K)-ATPase in developing brine shrimp Nauplii. Ann NY Acad Sci 402: 185–191PubMedCrossRefGoogle Scholar
  16. 16.
    Resh MD, Nemenoff RA, Guidotti G (1980) Insulin stimulation of (Na,K)-adenosine triphosphatase- dependent 86Rb+ uptake in rat adipocytes. J Biol Chem 255: 10938–10945PubMedGoogle Scholar
  17. 17.
    Smith TW, Butler VP Jr, Haber E (1970) Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin. Biochemistry 9: 331–337PubMedCrossRefGoogle Scholar
  18. 18.
    Sweadner KJ (1979) Two molecular forms of (Na+ + K+)~stimulated ATPase in brain. J Biol Chem 254: 6060–6067PubMedGoogle Scholar
  19. 19.
    Schwalb H, Dickstein Y, Heller M (1982) Interactions of cardiac glycosides with cardiac cells. Biochim Biophys Acta 689: 241–248PubMedCrossRefGoogle Scholar
  20. 20.
    Schwartz A, Whitmer K, Grupp G, Grupp I, Adams RJ, Lee SW (1983) Mechanism of action of digitalis: Is the Na,K-ATPase the pharmacological receptor? Ann. NY Acad Sci 402: 253–259CrossRefGoogle Scholar
  21. 21.
    Yanuka Y, Hallaq H, Heller M (1984) Submitted to Biochem Biophys Res CommGoogle Scholar
  22. 22.
    Yoda A (1973) Structure-acitivity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. Mol Pharmacol 9: 51–60PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • Michael Heller
    • 1
  1. 1.Laboratory for Myocardial Research, Institute of BiochemistryHebrew University — Hadassah Medical SchoolJerusalemIsrael

Personalised recommendations